| Literature DB >> 32295020 |
Youn-Jung Kim1, Min-Jee Kim2, Yong Seo Koo3, Won Young Kim1.
Abstract
We investigated the prognostic value of standard electroencephalography, a 30-min recording using 21 electrodes on the scalp, during the early post-cardiac arrest period, and evaluated the performance of electroencephalography findings combined with other clinical features for predicting favourable outcomes in comatose out-of-hospital cardiac arrest (OHCA) survivors treated with targeted temperature management (TTM). This observational registry-based study was conducted at a tertiary care hospital in Korea using the data of all consecutive adult non-traumatic comatose OHCA survivors who underwent standard electroencephalography during TTM between 2010 and 2018. The primary outcome was a 6-month favourable neurological outcome (Cerebral Performance Category score of 1 or 2). Among 170 comatose OHCA survivors with median electroencephalography time of 22 hours, a 6-month favourable neurologic outcome was observed in 34.1% (58/170). After adjusting other clinical characteristics, an electroencephalography background with dominant alpha and theta waves had the highest odds ratio of 13.03 (95% confidence interval, 4.69-36.22) in multivariable logistic analysis. A combination of other clinical features (age < 65 years, initial shockable rhythm, resuscitation duration < 20 min) with an electroencephalography background with dominant alpha and theta waves increased predictive performance for favourable neurologic outcomes with a high specificity of up to 100%. A background with dominant alpha and theta waves in standard electroencephalography during TTM could be a simple and early favourable prognostic finding in comatose OHCA survivors.Entities:
Keywords: electroencephalography; hypoxic brain damage; out-of-hospital cardiac arrest; prognosis
Year: 2020 PMID: 32295020 PMCID: PMC7230199 DOI: 10.3390/jcm9041113
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Example of predominant background electroencephalography frequency in out-of-hospital cardiac arrest survivors subjected to targeted temperature management. (A) Predominant alpha waves; (B) predominant theta waves; (C) predominant delta waves; (D) undetermined background electroencephalography.
Figure 2Patient flow diagram. Abbreviations: targeted temperature management (TTM); electroencephalography (EEG); return of spontaneous circulation (ROSC).
Demographic and clinical characteristics of patients with out-of-hospital cardiac arrest treated with targeted temperature management according to neurologic outcome at 6 months.
| Characteristics | Total ( | Favourable Neurologic Outcome ( | Unfavourable Neurologic Outcome ( | |
|---|---|---|---|---|
| Age, years | 60.0 (45.8–71.0) | 54.5 (39.0–64.3) | 62.0 (49.0–73.0) | <0.001 |
| Age < 65 years | 107 (62.9%) | 48 (82.8%) | 59 (52.7%) | <0.001 |
| Male | 113 (66.5%) | 42 (72.4%) | 71 (63.4%) | 0.238 |
| Previous medical history | ||||
| Hypertension | 58 (34.1%) | 14 (24.1%) | 44 (39.3%) | 0.048 |
| Diabetes mellitus | 43 (25.3%) | 8 (13.8%) | 34 (31.5%) | 0.013 |
| Acute myocardial infarction | 8 (4.7%) | 1 (1.7%) | 7 (6.3%) | 0.267 |
| Congestive heart failure | 12 (7.1%) | 4 (6.9%) | 8 (7.1%) | >0.999 |
| Chronic kidney disease | 20 (11.8%) | 3 (5.2%) | 17 (15.2%) | 0.055 |
| Malignancy | 13 (7.6%) | 3 (5.2%) | 10 (8.9%) | 0.382 |
| Arrest characteristics | ||||
| Witnessed | 127 (74.7%) | 49 (84.5%) | 78 (69.6%) | 0.035 |
| Bystander CPR | 120 (70.6%) | 39 (67.2%) | 81 (72.3%) | 0.491 |
| Initial shockable rhythm | 66 (38.8%) | 39 (67.2%) | 27 (24.1%) | <0.001 |
| No flow time, min | 0.0 (0.0–3.0) | 0.0 (0.0–4.0) | 0.0 (0.0–3.0) | 0.778 |
| Resuscitation duration, min | 22.0 (10.0–35.3) | 11.5 (6.0–20.8) | 26.5 (16.0–39.5) | <0.001 |
| Time from ROSC to target temperature, hours | 5.52 (3.93–7.43) | 5.75 (4.88–7.97) | 5.00 (3.76–7.47) | 0.069 |
| Target temperature | 0.679 | |||
| 33 °C | 150 (88.2%) | 52 (89.7%) | 98 (87.5%) | |
| 36 °C | 20 (11.8%) | 6 (10.3%) | 14 (12.5%) | |
| Phases of TTM at EEG examination | 0.730 | |||
| Induction | 15 (8.8%) | 6 (10.3%) | 9 (8.0%) | |
| Maintenance | 92 (54.1%) | 32 (55.2%) | 60 (53.6%) | |
| Rewarming | 20 (11.8%) | 8 (13.8%) | 12 (10.7%) | |
| Normothermia | 43 (25.3%) | 12 (20.7%) | 31 (27.7%) | |
| Time from ROSC to EEG examination, hours | 22.0 (12.8–40.3) | 21.0 (11.0–36.8) | 22.0 (13.3–42.5) | 0.581 |
| Treated sedatives | ||||
| Propofol | 139 (81.8%) | 56 (96.6%) | 83 (74.1%) | <0.001 |
| Max. propofol rate, mg/kg/h | 3.0 (2.0–4.0) | 3.0 (2.0–4.0) | 3.0 (1.5–4.0) | 0.166 |
| Remifentanil | 87 (51.2%) | 34 (58.6%) | 53 (47.3%) | 0.162 |
| Max remifentanil rate, µg/kg/h | 0.2 (0.1–0.2) | 0.2 (0.1–0.2) | 0.2 (0.1–0.2) | 0.258 |
| Morphine | 54 (31.8%) | 21 (36.2%) | 33 (29.5%) | 0.371 |
| Max morphine rate, mg/h | 2.5 (1.9–3.0) | 3.0 (2.0–3.5) | 2.0 (1.0–3.0) | 0.348 |
| Midazolam | 37 (21.8%) | 14 (24.1%) | 23 (20.5%) | 0.589 |
| Max midazolam rate, mg/kg/h | 0.10 (0.08–0.16) | 0.08 (0.04–0.11) | 0.10 (0.08–0.20) | 0.219 |
| Fentanyl | 2 (1.2%) | 0 (0%) | 2 (1.8%) | 0.548 |
| Treated neuromuscular blocking agent | 35 (20.6%) | 15 (25.9%) | 20 (17.9%) | 0.221 |
Values are expressed as median (interquartile ranges) or n (%) as appropriate. Abbreviations: CPR, cardiopulmonary resuscitation; ROSC, return of spontaneous circulation; EEG, electroencephalography.
Standard intermittent electroencephalography findings based on the standardized terminology of the American Clinical Neurophysiology Society.
| Characteristics | Total ( | Favourable Neurologic Outcome ( | Unfavourable Neurologic Outcome ( | |
|---|---|---|---|---|
| EEG background frequency | <0.001 | |||
| Dominant alpha waves | 61 (35.9%) | 36 (62.1%) | 25 (22.3%) | |
| Dominant theta waves | 17 (10.0%) | 14 (24.1%) | 3 (2.7%) | |
| Dominant delta waves | 15 (8.8%) | 2 (3.4%) | 13 (11.6%) | |
| Undetermined | 77 (45.3%) | 6 (10.3%) | 71 (63.4%) | |
| EEG background voltage | <0.001 | |||
| Attenuation or Suppressed (<10 μV) | 64 (37.6%) | 4 (6.9%) | 60 (53.6%) | |
| Low voltage (10–20 μV) | 13 (7.6%) | 4 (6.9%) | 9 (8.0%) | |
| Normal (>20 μV) | 93 (54.7%) | 50 (86.2%) | 43 (38.4%) | |
| Other background EEG findings | ||||
| Burst suppression or Burst attenuation | 22 (12.9%) | 2 (3.4%) | 20 (17.9%) | 0.008 |
| Reactivity to pain stimuli | 28 (16.5%) | 16 (27.6%) | 12 (10.7%) | 0.005 |
| Stage II Sleep transients | 9 (5.3%) | 6 (10.3%) | 3 (2.7%) | 0.064 |
| Epileptic form discharge | ||||
| Spike and wave or Sharp and wave | 14 (8.2%) | 4 (6.9%) | 10 (8.9%) | 0.774 |
| Rhythmic delta activity | 42 (24.7%) | 27 (46.6%) | 15 (13.4%) | <0.001 |
Abbreviations: EEG, electroencephalography.
Univariate and multivariate logistic regression analysis for a 6-month favourable neurologic outcome.
| Characteristics | Crude OR | 95% CI | Adjusted OR | 95% CI | ||
|---|---|---|---|---|---|---|
| Age, years | 0.950 | 0.921–0.980 | 0.001 | |||
| Female | 0.660 | 0.330–1.318 | 0.239 | |||
| Initial shockable rhythm | 6.462 | 3.213–12.996 | <0.001 | 7.158 | 2.779–20.334 | <0.001 |
| Witnessed | 2.373 | 1.048–5.372 | 0.038 | |||
| Bystander CPR | 0.786 | 0.395–1.562 | 0.491 | |||
| No flow time, min | 1.011 | 0.953–1.072 | 0.725 | |||
| Resuscitation duration, min | 0.959 | 0.938–0.982 | <0.001 | 0.966 | 0.939–0.993 | 0.015 |
| Predominant background EEG frequency | ||||||
| Undetermined | Reference | Reference | ||||
| Dominant alpha waves | 17.040 | 6.414–45.271 | <0.001 | 9.576 | 3.087–29.703 | <0.001 |
| Dominant theta waves | 55.222 | 12.325–247.425 | <0.001 | 31.843 | 5.861–173.017 | <0.001 |
| Dominant delta waves | 1.821 | 0.331–10.026 | 0.491 | 2.333 | 0.347–15.691 | 0.384 |
| Voltage of background EEG frequency | ||||||
| Normal | Reference | |||||
| Attenuation or Suppressed (<10 μV) | 0.057 | 0.019–0.171 | <0.001 | |||
| Low voltage (10–20 μV) | 0.382 | 0.110–1.329 | 0.130 | |||
| Other EEG findings | ||||||
| Burst suppression or Burst attenuation | 0.164 | 0.037–0.730 | 0.018 | |||
| Reactivity to pain stimuli | 3.175 | 1.383–7.286 | 0.006 | |||
| Stage II Sleep transients | 4.192 | 1.009–17.426 | 0.049 | |||
| Epileptic form discharge | ||||||
| Spike and wave or Sharp and wave | 0.756 | 0.226–2.522 | 0.649 | |||
| Rhythmic delta activity | 5.632 | 2.662–11.919 | <0.001 |
Abbreviations: odds ratio (OR); confidence interval (CI); cardiopulmonary resuscitation (CPR); electroencephalography (EEG).
Predictive value of clinical and EEG findings for favourable neurologic outcome (favourable neurologic outcome event/total patients = 58/170).
| Variables | Favourable Neurologic Outcome/Patient Numbers | Sensitivity | Specificity | PPV | NPV | Accuracy |
|---|---|---|---|---|---|---|
| EEG pattern | 50/78 | 86.2% | 75.0% | 64.1% | 91.3% | 78.8% |
| EEG pattern and/or rhythm | 55/100 | 94.8% | 59.8% | 55.0% | 95.7% | 71.8% |
| EEG pattern + age | 40/53 | 69.0% | 88.4% | 75.5% | 84.6% | 81.8% |
| EEG pattern + rhythm | 34/44 | 58.6% | 91.1% | 77.3% | 81.0% | 80.0% |
| EEG pattern + age + rhythm | 27/31 | 46.6% | 94.4% | 87.1% | 77.7% | 79.4% |
| EEG pattern + age + rhythm + resuscitation duration | 17/17 | 29.3% | 100.0% | 100.0% | 73.2% | 75.9% |
EEG pattern indicates a predominant background EEG frequency with dominant alpha and theta waves. Rhythm indicates initial shockable cardiac arrest rhythm. Age indicates an age under 65 years old. Resuscitation duration indicates <20 minutes. Abbreviations: positive predictive value (PPV); negative predictive value (NPV).